213 related articles for article (PubMed ID: 28891076)
1. Natural course and characteristics of cutaneous neurofibromas in neurofibromatosis 1.
Ehara Y; Yamamoto O; Kosaki K; Yoshida Y
J Dermatol; 2018 Jan; 45(1):53-57. PubMed ID: 28891076
[TBL] [Abstract][Full Text] [Related]
2. Clinical severity in Japanese patients with neurofibromatosis 1 based on DNB classification.
Ehara Y; Yamamoto O; Kosaki K; Yoshida Y
J Dermatol; 2017 Nov; 44(11):1262-1267. PubMed ID: 29098729
[TBL] [Abstract][Full Text] [Related]
3. Large number of cutaneous neurofibromas beyond age-appropriate incidence in a patient with a large deletion of NF1.
Yoshida Y; Ehara Y; Kosaki K; Yamamoto O
J Dermatol; 2018 Mar; 45(3):363-364. PubMed ID: 29498099
[No Abstract] [Full Text] [Related]
4. Cutaneous neurofibromas in Neurofibromatosis type I: a quantitative natural history study.
Cannon A; Chen MJ; Li P; Boyd KP; Theos A; Redden DT; Korf B
Orphanet J Rare Dis; 2018 Feb; 13(1):31. PubMed ID: 29415745
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and clinicopathological characteristics of lipomatous neurofibromas in neurofibromatosis 1: An investigation of 229 cutaneous neurofibromas and a systematic review of the literature.
Rozza-de-Menezes RE; Brum CAI; Gaglionone NC; de Sousa Almeida LM; Andrade-Losso RM; Paiva BVB; Faveret PLS; da Silva AV; Siqueira OHK; Riccardi VM; Cunha KS
J Cutan Pathol; 2018 Oct; 45(10):743-753. PubMed ID: 29959804
[TBL] [Abstract][Full Text] [Related]
6. The effect of pregnancy on growth-dynamics of neurofibromas in Neurofibromatosis type 1.
Well L; Jaeger A; Kehrer-Sawatzki H; Farschtschi S; Avanesov M; Sauer M; de Sousa MT; Bannas P; Derlin T; Adam G; Mautner VF; Salamon JM
PLoS One; 2020; 15(4):e0232031. PubMed ID: 32343738
[TBL] [Abstract][Full Text] [Related]
7. Distribution of diffuse plexiform neurofibroma on the body surface in patients with neurofibromatosis 1.
Ehara Y; Koga M; Imafuku S; Yamamoto O; Yoshida Y
J Dermatol; 2020 Feb; 47(2):190-192. PubMed ID: 31849109
[TBL] [Abstract][Full Text] [Related]
8. High-resolution 400K oligonucleotide array comparative genomic hybridization analysis of neurofibromatosis type 1-associated cutaneous neurofibromas.
Asai A; Karnan S; Ota A; Takahashi M; Damdindorj L; Konishi Y; Hossain E; Konishi H; Nagata A; Yokoo K; Hosokawa Y
Gene; 2015 Mar; 558(2):220-6. PubMed ID: 25562418
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological study of neurofibromatosis type 1: an experience in Nigeria.
Odebode TO; Afolayan EA; Adigun IA; Daramola OO
Int J Dermatol; 2005 Feb; 44(2):116-20. PubMed ID: 15689208
[TBL] [Abstract][Full Text] [Related]
10. Is the distribution of dermal neurofibromas in neurofibromatosis type 1 (NF1) related to the pattern of the skin surface temperature?
Kaufmann D; Tinschert S; Algermissen B
Eur J Dermatol; 2001; 11(6):521-6. PubMed ID: 11701400
[TBL] [Abstract][Full Text] [Related]
11. Clinical and molecular characterization of 112 single-center patients with Neurofibromatosis type 1.
Corsello G; Antona V; Serra G; Zara F; Giambrone C; Lagalla L; Piccione M; Piro E
Ital J Pediatr; 2018 Apr; 44(1):45. PubMed ID: 29618358
[TBL] [Abstract][Full Text] [Related]
12. Chromosome 17 loss-of-heterozygosity studies in benign and malignant tumors in neurofibromatosis type 1.
Rasmussen SA; Overman J; Thomson SA; Colman SD; Abernathy CR; Trimpert RE; Moose R; Virdi G; Roux K; Bauer M; Rojiani AM; Maria BL; Muir D; Wallace MR
Genes Chromosomes Cancer; 2000 Aug; 28(4):425-31. PubMed ID: 10862051
[TBL] [Abstract][Full Text] [Related]
13. NF1 mutations in neurofibromatosis 1 patients with plexiform neurofibromas.
Kluwe L; Friedrich RE; Korf B; Fahsold R; Mautner VF
Hum Mutat; 2002 Mar; 19(3):309. PubMed ID: 11857752
[TBL] [Abstract][Full Text] [Related]
14. The presence and progression of choroidal neurofibromas in a predominantly pediatric population with neurofibromatosis type-1.
Chilibeck CM; Shah S; Russell HC; Vincent AL
Ophthalmic Genet; 2021 Jun; 42(3):223-229. PubMed ID: 33594930
[No Abstract] [Full Text] [Related]
15. Clinical features of 58 Japanese patients with mosaic neurofibromatosis 1.
Tanito K; Ota A; Kamide R; Nakagawa H; Niimura M
J Dermatol; 2014 Aug; 41(8):724-8. PubMed ID: 25041723
[TBL] [Abstract][Full Text] [Related]
16. Atypical neurofibromas in neurofibromatosis type 1 are premalignant tumors.
Beert E; Brems H; Daniëls B; De Wever I; Van Calenbergh F; Schoenaers J; Debiec-Rychter M; Gevaert O; De Raedt T; Van Den Bruel A; de Ravel T; Cichowski K; Kluwe L; Mautner V; Sciot R; Legius E
Genes Chromosomes Cancer; 2011 Dec; 50(12):1021-32. PubMed ID: 21987445
[TBL] [Abstract][Full Text] [Related]
17. Epidemiological Analysis of Major Complications Requiring Medical Intervention in Patients with Neurofibromatosis 1.
Yoshida Y; Ehara Y; Koga M; Imafuku S; Yamamoto O
Acta Derm Venereol; 2018 Aug; 98(8):753-756. PubMed ID: 29796689
[TBL] [Abstract][Full Text] [Related]
18. Head circumference and anthropometric changes and their relation to plexiform and skin neurofibromas in sporadic and familial neurofibromatosis 1 Brazilian adults: a cross-sectional study.
Basto DL; de Souza Vieira G; Andrade-Losso RM; Almeida PN; Riccardi VM; Rozza-de-Menezes RE; Cunha KS
Orphanet J Rare Dis; 2022 Sep; 17(1):341. PubMed ID: 36064430
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D deficiency associated with number of neurofibromas in neurofibromatosis 1.
Lammert M; Friedman JM; Roth HJ; Friedrich RE; Kluwe L; Atkins D; Schooler T; Mautner VF
J Med Genet; 2006 Oct; 43(10):810-3. PubMed ID: 16571643
[TBL] [Abstract][Full Text] [Related]
20. Validity and interexaminer reliability of a new method to quantify skin neurofibromas of neurofibromatosis 1 using paper frames.
Cunha KS; Rozza-de-Menezes RE; Andrade RM; Theos A; Luiz RR; Korf B; Geller M
Orphanet J Rare Dis; 2014 Dec; 9():202. PubMed ID: 25475340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
